|
CHCHD3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.66533453693773E-15 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.84440018813348E-10 |
| Normal-vs-Stage2 |
1.190490E-02 |
| Normal-vs-Stage3 |
5.019600E-02 |
| Normal-vs-Stage4 |
3.162300E-02 |
| Stage1-vs-Stage2 |
8.844600E-01 |
| Stage1-vs-Stage3 |
1.690230E-01 |
| Stage1-vs-Stage4 |
8.892600E-01 |
| Stage2-vs-Stage3 |
2.770400E-01 |
| Stage2-vs-Stage4 |
9.816600E-01 |
| Stage3-vs-Stage4 |
3.224800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.57887069874141E-13 |
| Normal-vs-AfricanAmerican |
9.35139999991286E-07 |
| Normal-vs-Asian |
4.062800E-01 |
| Caucasian-vs-AfricanAmerican |
9.865600E-01 |
| Caucasian-vs-Asian |
7.248800E-01 |
| AfricanAmerican-vs-Asian |
7.033200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.71751501909512E-12 |
| Normal-vs-Female |
4.06100000005516E-06 |
| Male-vs-Female |
9.953200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.275100E-03 |
| Normal-vs-Extreme_Weight |
5.82049997088774E-09 |
| Normal-vs-Obese |
1.67099999948128E-07 |
| Normal-vs-Extreme_Obese |
8.330000E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.272400E-01 |
| Normal_Weight-vs-Obese |
5.592600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.309600E-01 |
| Extreme_Weight-vs-Obese |
6.493400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.304000E-01 |
| Obese-vs-Extreme_Obese |
7.432200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.003700E-02 |
| Normal-vs-Age(41-60Yrs) |
8.74820216267835E-11 |
| Normal-vs-Age(61-80Yrs) |
2.03170003043596E-09 |
| Normal-vs-Age(81-100Yrs) |
7.515900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.692570E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.488400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.068600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.036400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.812000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.757000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
3.95250000000402E-05 |
| Normal-VS-KIRP CIMP |
6.008600E-01 |
| Normal-VS-Unclassified PRCC |
9.458200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.761600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.216700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.456100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.391600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.541600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.363900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.641310E-03 |
| Normal-vs-N1 |
2.394200E-01 |
| Normal-vs-N2 |
1.712820E-01 |
| N0-vs-N1 |
3.163400E-01 |
| N0-vs-N2 |
4.852800E-01 |
| N1-vs-N2 |
2.556200E-01 |
|
|
